Pillstats
Rx only · Capsule, Extended Release · Oral

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate

Brands: Mixed Salts Of A Single Entity Amphetamine Product Xr · Mixed Salts Of A Single-Entity Amphetamine Product · Amphetamine Aspartate Monohydrate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US23 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers4 labelers
Packages23
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.01$2.02$3.02$4.03Dec 2025Mar 2026Jun 2026
$3.359
Latest avg · Jun 17, 2026
-2%
Since Dec 17, 2025
4
Active US suppliers
70%
Top-2 supplier share*

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SpecGx LLCunknown10SUPPLYING
Actavis Pharma, Inc.unknown6SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown4SUPPLYING
Catalent Pharma Solutions, LLCunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.